⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLPT News
ClearPoint Neuro, Inc. Common Stock
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
accessnewswire.com
CLPT
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
accessnewswire.com
CLPT
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
accessnewswire.com
CLPT
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
accessnewswire.com
CLPT
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
accessnewswire.com
CLPT
ClearPoint Neuro Reports Second Quarter 2025 Results
accessnewswire.com
CLPT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT
prnewswire.com
CLPT